Melissa Molyneux, MD

Family Medicine / Primary Care

image coming soon

Patient Satisfaction Survey

Overall Satisfaction
4.8 out of 5
4 Ratings
6 Comments

Education

  • Medical Degree: University of Arizona College of Medicine, Phoenix, AZ
  • Residency: Phoenix Baptist Hospital/Abrazo Central Campus Family Medicine Residency, Phoenix, AZ

Special Interests

Melissa Molyneux, MD, is a board-certified physician in family medicine with a special interest in its full-spectrum practice, including acute and critical care, inpatient services, low-risk obstetrics and gynecology, and humanism and medical ethics.  She was granted the GOLD Humanism award by her peers in medical school and the Humanism in Medicine award by her peers in residency.  She is involved with the Family Medicine Clinic Residency as core faculty and in developing a hospitalist track.  She has presented her research at national conferences and has been published in medical journals.

Services

  • Urgent care
  • Primary care of chronic diseases
  • Low-risk prenatal care and deliveries
  • Women’s health services
  • General pediatrics
  • Inpatient medicine and procedures

Patient Ratings & Comments

The Patient Rating score is an average of all responses to provider related questions on our independently administered Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
4.7
Friendliness/courtesy of Care provider
5
Likelihood of recommending Care provider
4.7
Care provider efforts to include in decisions
4.7
Care provider explanations of prob/condition
4.7
Care provider concern for questions/worries
4.7
Patients' confidence in Care provider
5
Care provider spoke using clear language

Comments

Comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
Feb 4, 2019
Very friendly & efficient as usual. Answered all my questions.
Feb 4, 2019
All good!
Feb 4, 2019
All good.
Feb 4, 2019
All good!
Feb 4, 2019
All good.
Feb 4, 2019
All good!